Skip to content

Randomized Control Trials of Surgery for Pediatric OSA

Randomized Controlled Studies of Sugery for Pediatric OSA: Part 1 Expectancy Compared to Adeno-tonsillectomy for Mild-moderate OSA. Part 2 Adeno-tonsillectomy Compared to Adeno-pharyngoplasty for Severe OSA.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02315911
Enrollment
143
Registered
2014-12-12
Start date
2014-12-31
Completion date
2019-03-31
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otorhinolaryngologic Diseases, Pediatric Disorder, Sleep Apnea, Obstructive

Keywords

Tonsillectomy, Adenoidectomy, Adenoidpharyngoplasty, OSA

Brief summary

Randomized study on pediatric OSA with 2 groups: mild-moderate OSA and severe OSA. Mild-moderate are randomized to either expectancy or ATE. Severe are randomized to either ATE or APP. Pediatric age span of 2 until 4,9 years.

Detailed description

Children who are referred to ENT clinic because of sleep-disordered breathing and fulfil the inclusion criteria undergo polysomnography (PSG) and fill in questionnaires. Depending on the outcome of the PSG, whether a) the child have mild to moderate OSA (AHI between 2-9.9) the family is asked to be in the study. If yes, the doctor take a sealed envelope and open it, either the child are randomized to adenotonsillectomy (ATE) or 6 months expectancy. Whether PSG shows b) severe OSA and the family accept participation the child is operated within a month. There is a straification beetween 2 groups, if AHI is 1) between 10 and 29.9 or 2) above 30. A sealed envelope is open in the operating room by the surgeon. The child is randomized to either ATE or ATE and suturing of the tonsillar pillars. The study is blinded for the family, who will not know which method the child has undergone. After 6 months all children will undergo follow-up with PSG and questionnaires. If the expectancy group will deteriorate during waiting time, or the child still has moderate to severe OSA, they will undergo ATE. Further follow-ups at three and ten years. Altogether 160 children should be evaluated with two PSG, 80 in each group.

Interventions

PROCEDUREATE

surgical removal of adenoids and tonsils

PROCEDUREAPP

surgical removal of adenoids and tonsils and suturing of palatal pillars

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 5 Years
Healthy volunteers
No

Inclusion criteria

* OAHI \>= 2 * Tonsillary hypertrophy, Brodsky size 2-4 * Adequate swedish knowledge

Exclusion criteria

* Cardiovascular disorders * Pulmonary disorders * Neuromuscular disorders * Cranoifacial malformations * Genetic disorders * Earlier performed adenoid-tonsillary-surgery * Bleeding disorders

Design outcomes

Primary

MeasureTime frameDescription
obstructive apnea hypopnea index6 monthswith full-night polysomnography

Secondary

MeasureTime frameDescription
oxygen desaturation index6 monthswith full-night polysomnography
postoperative pain6 monthsvisuell analog scale, questionnaire diaries. Number of days until normal diet.
per- and postoperative bleedingpostoperatively, weeksdescription of bleeding amount per and postoperatively, number of patients needed to reoperate because of bleeding postoperatively
Innate lymphoid cells in tonsils6 monthsTo investigate the amount of Innate lymphoid cells in children with OSA
side-effects of surgery6 monthswith a questionnaire evaluate if the child postoperatively will have speech-or swallowing difficulties. The parents will respond with a four-point Likert scale
quality of life6 monthsQuestionnaires validated, SDQ and OSA-18

Other

MeasureTime frameDescription
longterm results3 yearswith new polysomnography and questionnaires. Evaluate number of patients that are cured, AHI below 2.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026